Renal dysfunction during treatment of chronic hepatitis B with tenofovir disoproxyl fumarate and associated risk factors.,European Journal of Gastroenterology & Hepatology

当前位置： X-MOL 学术 › Eur. Gastroenterol. Hepatol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Renal dysfunction during treatment of chronic hepatitis B with tenofovir disoproxyl fumarate and associated risk factors.
European Journal of Gastroenterology & Hepatology ( IF 2.1 ) Pub Date : 2024-02-16 , DOI: 10.1097/meg.0000000000002723
Alessandra M. de A. Maciel _{1,

2} , Maria Lucia C. G. Ferraz ₁ , Renata de M. Perez ₁ , Carlos Eduardo Brandão-Mello ₂

Affiliation

To analyze the evolution of glomerular filtration rate (GFR) and the presence of renal tubular dysfunction during the treatment of chronic hepatitis B virus (HBV) infection with tenofovir disoproxil fumarate (TDF) and to determine the risk factors involved.

中文翻译：